Thanks, the Hadza study looks interesting. I’d have to read carefully at length to have a strong opinion on it but it seems like a good way to estimate the long-run target. I agree 16,000 is probably too much to take chronically, I’ve been staying below the TUL of 10,000, and expect to reduce the dosage significantly now that it’s been a few years and COVID case rates are waning.
Thanks, the Hadza study looks interesting. I’d have to read carefully at length to have a strong opinion on it but it seems like a good way to estimate the long-run target. I agree 16,000 is probably too much to take chronically, I’ve been staying below the TUL of 10,000, and expect to reduce the dosage significantly now that it’s been a few years and COVID case rates are waning.